CTOR
Citius Oncology, Inc.
NASDAQ: CTOR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.88
+2.31% today
Updated 2026-04-30
Market cap
$77.43M
P/E ratio
—
P/S ratio
19.63x
EPS (TTM)
$-0.31
Dividend yield
—
52W range
$0 – $6
Volume
0.3M
Citius Oncology, Inc. (CTOR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |